| Celebrex Cancer |
|
|
|
|
»
The National Cancer Institute Discovers Problems with Celebrex
|
|
The National Cancer Institute (NCI) has stopped the administration of Celebrex (celecoxib) in their ongoing clinical trial. The NCI was investigating the use of the drug for preventing colon polyps. The clinical trial involved three groups of patients. One group was administered 400 mg of Celebrex twice daily, one group was administered 200 mg of Celebrex twice daily, and a third group was administered a placebo. The average duration in the trail was 33 months.
|
»
Celebrex Law Suits Looking Like a Strong Case
|
|
There is no data as yet that indicates how many former patients of Pfizer's anti-inflammatory and painkilling drug are filing Celebrex law suits, but given the magnitude of the company's perceived crime it is likely that there will be very many. And even a quick perusal of the alleged behaviour of the company regarding this drug seems to point to Celebrex law suits being something of a fait accompli.
|
|
|
/Images/icon_Blogs.gif){kind=icon}
/Images/icon_Authors.gif){kind=icon}
/Images/icon_Author.gif){kind=icon}
/Images/icon_Login.gif){kind=icon}
/Images/icon_Article.gif){kind=icon}
/Images/icon_MyArticles.gif){kind=icon}
/Images/icon_FullStory.gif){kind=icon}
full story